We describe herein the European Reference Network on Rare Endocrine Conditions clinical practice guideline on diagnosis and management of familial forms of hyperaldosteronism. The guideline panel consisted of 10 experts in primary aldosteronism, endocrine hypertension, paediatric endocrinology, and cardiology as well as a methodologist. A systematic literature search was conducted, and because of the rarity of the condition, most recommendations were based on expert opinion and small patient series. The guideline includes a brief description of the genetics and molecular pathophysiology associated with each condition, the patients to be screened, and how to screen. Diagnostic and treatment approaches for patients with genetically determined diagnosis are presented. The recommendations apply to patients with genetically proven familial hyperaldosteronism and not to families with more than one case of primary aldosteronism without demonstration of a responsible pathogenic variant.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/ejendo/lvae041 | DOI Listing |
Intern Med J
November 2024
Endocrinology Unit, Te Whatu Ora Waikato, Hamilton, New Zealand.
Anatol J Cardiol
June 2024
Division of General Internal Medicine, Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Türkiye;Hacettepe University, Center for Genomics and Rare Diseases, Ankara, Türkiye.
Mendelian forms of renin-angiotensin-aldosterone system (RAAS)-related hypertension, commonly referred to as monogenic hypertension, represent a rare but significant subset of hypertensive disorders characterized by genetic mutations that disrupt the normal physiological mechanisms of blood pressure regulation. This review focuses on elucidating the germline mutations affecting RAAS pathways that lead to distinct forms of heritable hypertension. By understanding the pathophysiological basis of conditions such as Gordon's syndrome, Liddle syndrome, congenital adrenal hyperplasia, and familial hyperaldosteronism types, this review aims to highlight the unique clinical features, diagnostic challenges, and therapeutic implications associated with these disorders.
View Article and Find Full Text PDFJ Hypertens
September 2024
Fuwai Yunnan Cardiovascular Hospital, Kunming City, Yunnan Province, China.
Primary aldosteronism is the most common cause of secondary hypertension, which is caused by increased aldosterone secretion in the adrenal cortex and contains many subtypes, among which familial hyperaldosteronism is relatively rare. Familial hyperaldosteronism can be divided into four subtypes based on its clinical manifestations and mutated genes: FH-I , FH-II , FH-III , and FH-IV . This article reports on three patients with FH-IV: a mother and her two sons.
View Article and Find Full Text PDFEur J Endocrinol
June 2024
Department of Endocrinology-Diabetes Mellitus and Nutrition, Amiens University Hospital, 80054 Amiens, France.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!